Company: BNBX
Filing Date: 2025-04-15
Form Type: DEF 14A
Source: 0001104659-25-034898
Chunk: 5

Company: BNB PLUS CORP.
Filing Date: 2025-04-15
Form: DEF 14A
Chunk 5
---
 in connection with the solicitation by the Board of Directors of the Company (referred to herein as the “ Board of Directors ” or the “ Board ”) of proxies, in the accompanying form, to be used at the Annual Meeting to be held at 11:00 a.m., Eastern Time, on May 22, 2025 and any postponements or adjournments thereof. This Proxy Statement along with the accompanying Notice of Annual Meeting of Stockholders summarizes the purposes of the Annual Meeting and the information you need to know to vote at the Annual Meeting. This Proxy Statement is being mailed on or about April 15, 2025 to all stockholders entitled to notice of and to vote at the Annual Meeting. You can also find a copy of our Annual Report on Form 10-K, as amended, for the year ended September 30, 2024 (the “Annual Report”), which includes our financial statements for the fiscal year ended September 30, 2024 by following the instructions contained in the Notice of Annual Meeting mailed to stockholders entitled to notice of and to vote at the Annual Meeting along with this Proxy Statement on April 15, 2025. What is the purpose of the Annual Meeting? At our Annual Meeting, stockholders will act upon the matters outlined in the notice of meeting accompanying this Proxy Statement, consisting of (i) the election of six directors; (ii) the ratification of the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for the fiscal year ending September 30, 2025; (iii) the authorization of a reverse stock split of our common stock, $0.001 par value (“ Common Stock ”), at a ratio in the range from one-for-five to one-for-fifty, with such specific ratio to be determined by the Company’s Board of Directors following the Annual Meeting (the “ Reverse Split Proposal ”); (iv) the approval, in accordance with Nasdaq Listing Rule 5635(d), of the exercisability of certain common stock purchase warrants, and the issuance of Common Stock, underlying such warrants, which warrants were issued in connection with an offering of securities of the Company that occurred on October 30, 2024 (the “ Warrant Exercise Proposal ”); (v) the approval of an amendment to the Company’s 2020 Equity Incentive Plan (the “ Plan Amendment ”) to increase the number of authorized shares of common stock reserved for issuance by three million shares (the “ Plan Amendment Proposal ”